Jeffrey D. Marrazzo, Co-Founder and CEO of Sp...
David Nierengarten, Managing Director, Wedbus...
In July, Biogen signed a potential $1 billion...
Dry eye remains one of the more dynamic secto...
Eleven Biotherapeutics last spring issued som...
The Ophthalmology Innovation Summit hit it bi...